INBIOGEN CO.,Ltd Logo

INBIOGEN CO.,Ltd

Data mining, bioinformatics, and virtual assistance for the life sciences industry.

101140 | KO

Overview

Corporate Details

ISIN(s):
KR7101140002
LEI:
Country:
South Korea
Address:
서울특별시 강남구 언주로135길 21 2층(논현동), 강남구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Inbiogen is a life sciences company focused on providing virtual assistance and data mining services to the biotechnology and pharmaceutical industries. The company leverages a team of scientists and bioinformatics specialists to offer a range of services, including bioinformatics analysis, protein modeling, custom database development, and virtual research assistance. It aims to help international biotech companies and research organizations address challenges by extracting valuable knowledge from large datasets. In addition to its core scientific services, Inbiogen also provides marketing assistance and web design and development tailored to the life sciences sector, focusing on delivering customized and cost-effective solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 749.8 KB
2025-07-28 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 85.5 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 831.3 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 24.4 KB
2025-03-31 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.0 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 12.4 KB
2025-03-21 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 395.1 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 19.5 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 148.6 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 115.1 KB
2025-03-12 00:00
Earnings Release
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 20.0 KB
2025-03-12 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 12.3 KB
2025-01-22 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 11.6 KB
2025-01-10 00:00
Regulatory News Service
[기재정정]사업보고서 (2022.12)
Korean 442.9 KB
2025-01-10 00:00
Regulatory News Service
[기재정정]사업보고서 (2023.12)
Korean 1.1 MB

Automate Your Workflow. Get a real-time feed of all INBIOGEN CO.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for INBIOGEN CO.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for INBIOGEN CO.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Atomera Inc Logo
Licenses semiconductor material and IP to enhance transistor performance and power efficiency.
United States of America
ATOM
Atrae, Inc. Logo
Develops People Tech solutions for HR, including big data job sites and organizational analytics.
Japan
6194
Developing uranium and battery minerals for the nuclear energy and energy storage markets.
Australia
AEE
Avalo Therapeutics, Inc. Logo
Clinical-stage biotech developing IL-1β therapies for immune inflammatory diseases.
United States of America
AVTX
AVIS BUDGET GROUP, INC. Logo
Global provider of car rental, truck rental, and car-sharing for business & leisure travelers.
United States of America
CAR
Azenta, Inc. Logo
Life science solutions for pharma & biotech, offering sample management, storage & multiomics.
United States of America
AZTA
BayCurrent, Inc. Logo
Comprehensive consulting on strategy, AI, and digital transformation for corporations and government.
Japan
6532
BenevolentAI Logo
An AI-powered drug discovery platform accelerating R&D for scientists and pharmaceutical partners.
United Kingdom
BAI
BerGenBio Logo
Develops first-in-class AXL kinase inhibitors for cancer and severe respiratory infections.
Norway
BGBIO
Bergman & Beving Logo
Acquires and develops niche companies with solutions for the industrial and construction sectors.
Sweden
BERG

Talk to a Data Expert

Have a question? We'll get back to you promptly.